WARDLEY ELECTRONICS LIMITED
Company number 03955749 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Wardley Electronics Limited
1. Financial Health Score: B
Explanation: Wardley Electronics presents the financial profile of a mature business with substantial accumulated wealth but displaying recent symptoms of contraction. The company's strong asset base and low leverage provide robust structural health—like a patient with excellent bone density—but declining performance metrics in the latest year suggest the business may be entering a period of reduced vitality. The significant cash improvement is a positive vital sign, but the overall trajectory warrants careful monitoring.
2. Key Vital Signs
Net Assets (The "Heartbeat")
| Year | Net Assets | Year-on-Year Change |
|---|---|---|
| 2016 | £162,280 | — |
| 2019 | £348,297 | — |
| 2022 | £978,461 | — |
| 2023 | £1,161,693 | +18.7% |
| 2024 | £1,171,305 | +0.8% |
| 2025 | £1,100,109 | -6.1% |
Interpretation: The company enjoyed a remarkable growth trajectory from 2016 to 2023, building net assets from £162,280 to over £1.16 million—a sevenfold increase that speaks to years of healthy profitability. However, the 2025 decline of £71,196 signals the first meaningful contraction. This is like a patient who has been steadily building fitness but has recently started experiencing fatigue—the underlying constitution remains strong, but something has changed.
Cash Position (The "Blood Pressure")
| Year | Cash |
|---|---|
| 2019 | £122 |
| 2023 | £0 |
| 2024 | £751 |
| 2025 | £65,135 |
Interpretation: This is the most encouraging vital sign. After years of dangerously low cash reserves (essentially empty veins), the company has achieved a meaningful cash balance. This 87-fold increase suggests either improved cash collection, reduced investment, or potentially a deliberate strategy to build liquidity reserves. Like a patient whose blood pressure has normalized after years of being concerningly low, this deserves recognition.
Liquidity Ratio (The "Circulatory Health")
| Metric | 2025 | 2024 |
|---|---|---|
| Current Assets | £874,247 | £1,021,787 |
| Current Liabilities | £287,952 | £247,667 |
| Current Ratio | 3.04:1 | 4.13:1 |
| Quick Ratio (ex-stock) | 1.67:1 | 1.79:1 |
Interpretation: Both ratios remain in healthy territory—well above the 1:1 danger threshold. The slight deterioration reflects increased current liabilities rather than reduced current assets. Think of this as slightly elevated cholesterol: not immediately dangerous, but worth monitoring.
Leverage (The "Debt Burden on the Chest")
| Metric | 2025 | 2024 |
|---|---|---|
| Total Liabilities | £387,158* | £466,154* |
| Net Assets | £1,100,109 | £1,171,305 |
| Debt-to-Equity Ratio | 0.35:1 | 0.40:1 |
| Secured Bank Loans | £94,766 | £178,058 |
*Calculated from balance sheet totals
Interpretation: Leverage has improved significantly. The company has reduced its secured bank loans by £83,292 (47%) and total long-term liabilities by £121,431. This is like a patient successfully paying down their mortgage—the financial weight on the chest is lifting.
Stock Levels (The "Inventory Bloat")
| Year | Stock |
|---|---|
| 2024 | £578,225 |
| 2025 | £394,139 |
| Change | -31.8% |
Interpretation: A significant stock reduction could indicate improved inventory management or, more concerningly, reduced order volume. Given the concurrent decline in debtors and employees, this may reflect a contraction in trading activity rather than efficiency gains.
3. Diagnosis
Overall Financial Condition: Stable but Showing Early Symptoms of Contraction
The Growth Story (2016-2023): For seven consecutive years, Wardley Electronics demonstrated exceptional financial health. Net assets grew from £162,280 to £1,161,693—a compound annual growth rate of approximately 32%. This is the financial equivalent of a patient in peak physical condition, building strength year after year.
The Recent Deterioration (2024-2025): Multiple symptoms now suggest the business is contracting:
-
Profitability Decline: The reduction in retained earnings from £1,171,125 to £1,099,929 indicates a loss of approximately £71,196 for the year (assuming no dividends were paid from the minimal £180 share capital). This is the financial equivalent of an unexplained weight loss—concerning until the cause is identified.
-
Asset Contraction: Total assets have fallen from a peak of £2,043,940 (2023) to £1,487,267 (2025)—a 27.2% decline over two years. While some of this reflects debt reduction, the magnitude is significant.
-
Workforce Reduction: Employee numbers dropped from 14 to 12, suggesting either efficiency improvements or, more likely given other indicators, reduced trading activity.
-
Creditor Pressure: Trade creditors increased by 23.4% (£60,608 to £74,756) and other creditors surged by 137% (£37,251 to £88,236). This may indicate slower payment to suppliers—a classic symptom of cash flow stress, though paradoxically the cash position improved.
-
Debtors Decline: Trade debtors fell from £411,883 to £333,338, which could indicate better collection or simply fewer sales.
The Positive Diagnosis: The company is not in distress. With £1.1 million in net assets, a current ratio of 3:1, and £65,000 in cash, Wardley Electronics has substantial financial reserves to weather difficulties. The aggressive debt reduction suggests management is actively strengthening the balance sheet—perhaps anticipating tougher conditions ahead.
The Property Anchor: Land and buildings valued at £428,617 (not depreciated, suggesting freehold) provide a substantial asset base that is likely undervalued at historical cost. This property represents 38% of net assets and provides significant security.
4. Recommendations
Immediate Actions (The "Treatment Plan")
-
Investigate the Loss: Determine the root cause of the £71,196 decline in retained earnings. Is this a one-off event or the beginning of a trend? Like any unexplained symptom, it requires diagnosis before treatment.
-
Review Other Creditors: The 137% increase in other creditors (from £37,251 to £88,236) needs explanation. This could represent accrued expenses, director loans, or other obligations that may create future cash pressure.
-
Monitor Trade Creditor Days: With trade creditors rising while the business appears to be contracting, calculate creditor days to ensure the company isn't stretching payments to preserve cash—a practice that can damage supplier relationships.
Medium-Term Strategies (The "Rehabilitation Programme")
-
Property Valuation: Given that land and buildings are held at historical cost, obtain a current market valuation. This may reveal significant hidden reserves and could unlock refinancing opportunities at more favourable rates.
-
Cash Deployment Strategy: With £65,135 now sitting in cash, consider whether this is being held for a specific purpose or is excess liquidity. In the current interest rate environment, ensure this cash is working for the business.
-
Stock Management: The 31.8% stock reduction should be analysed—is this a deliberate just-in-time strategy or a symptom of reducing order volumes? If the former, celebrate; if the latter, address the underlying demand issues.
Long-Term Health (The "Wellness Programme")
-
Succession Planning: With Beryl Burns Tyldesley and Ralph Robert Tyldesley resigning as directors in March 2026, and Stuart James Tyldesley now holding over 75% control, ensure business continuity planning is in place. The concentration of control in one person creates both operational and governance risks.
-
Diversification Review: As a manufacturer of electronic components, assess exposure to sector-specific risks and consider whether the current contraction reflects industry-wide challenges or company-specific issues.
-
Working Capital Cycle: With £394,139 in stock, £333,338 in trade debtors, and £74,756 in trade creditors, the working capital cycle requires approximately £652,721 of funding. Review whether this level is optimal for current trading volumes.
Risk Indicators Summary
| Risk Factor | Status | Severity |
|---|---|---|
| Profitability decline | ⚠️ Present | Medium |
| Cash improvement | ✅ Positive | — |
| Asset contraction | ⚠️ Present | Medium |
| Debt reduction | ✅ Positive | — |
| Creditor increase | ⚠️ Present | Low-Medium |
| Governance concentration | ⚠️ Present | Medium |
| Liquidity position | ✅ Healthy | — |